KRPIA calls for reappraisal of medical insurance drug prices

Published: 2002-05-31 06:59:00

Updated: 2002-05-31 06:59:00

The Korean Research-based Pharmaceutical Industry Association (KRPIA) has recently demanded the reappraisal of medical insurance drug prices through the previous review, according to its statement submitted to the Ministry of Health and Welfare. The KRPIA further notes in its statement:

- As f...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK